Article
An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development.
Nature communications - 4 Jun 2020
Shankar Sunita, Tien Jean Ching-Yi, Siebenaler Ronald F, Chugh Seema, Dommeti Vijaya L, Zelenka-Wang Sylvia, Wang Xiao-Ming, Apel Ingrid J, Waninger Jessica, Eyunni Sanjana, Xu Alice, Mody Malay, Goodrum Andrew, Zhang Yuping, Tesmer John J, Mannan Rahul, Cao Xuhong, Vats Pankaj, Pitchiaya Sethuramasundaram, Ellison Stephanie J, Shi Jiaqi, Kumar-Sinha Chandan, Crawford Howard C, Chinnaiyan Arul M
Abstract excerpt
Both KRAS and EGFR are essential mediators of pancreatic cancer development and interact with Argonaute 2 (AGO2) to perturb its function. Here, in a mouse model of mutant KRAS-driven pancreatic cancer, loss of AGO2 allows precursor lesion (PanIN) formation yet prevents progression to pancreatic ductal adenocarcinoma (PDAC). Precursor lesions with AGO2 ablation undergo oncogene-induced senescence with altered...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
